A Modified Form of Vitamin A May Finally Slow a Rare Vision Disease
A 2026 JAMA Ophthalmology trial found gildeuretinol, a modified form of vitamin A, slowed retinal lesion growth by 21.
Useful takeaways from this story.
A 2026 JAMA Ophthalmology trial found gildeuretinol, a modified form of vitamin A, slowed retinal lesion growth by 21.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
A 2026 JAMA Ophthalmology trial found gildeuretinol, a modified form of vitamin A, slowed retinal lesion growth by 21.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.